Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement.
Anderlini
Paolo
P
Swanston
Nancy
N
Rashid
Ashif
A
Bueso-Ramos
Carlos
C
Macapinlac
Homer A
HA
Champlin
Richard E
RE
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001706:Biopsy; D001761:Bleomycin; D001853:Bone Marrow / Q000473:pathology; D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology; D003606:Dacarbazine; D004317:Doxorubicin; D020350:Graft vs Tumor Effect; D006689:Hodgkin Disease / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography; D012867:Skin / Q000473:pathology; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014747:Vinblastine
D007166:Immunosuppressive Agents; D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin